SCHEMBL28838539

SCHEMBL28838539

O=C(O)NCC(S)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5002095 0.78
SCHEMBL16346169 0.78
SCHEMBL6729103 0.76
SCHEMBL6728519 0.76
SCHEMBL6718794 0.74
SCHEMBL9065836 0.69
SCHEMBL3122891 0.69 CYP2D6 (0.57)
SCHEMBL3899246 0.69 CYP2D6 (0.50)
SCHEMBL2337647 0.69 CYP2D6 (0.50)
SCHEMBL402167 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115873020-A RAS inhibitors 锐新医药公司 2023-03-31 CN claimed
CN-114901366-A RAS inhibitors 锐新医药公司 2022-08-12 CN claimed
CN-115916194-A Methods for delaying, preventing and treating acquired resistance to RAS inhibitors 锐新医药公司 2023-04-04 CN disclosed
CN-115873020-A RAS inhibitors 锐新医药公司 2023-03-31 CN disclosed
CN-114901366-A RAS inhibitors 锐新医药公司 2022-08-12 CN disclosed